Adam V.
- Country
- Czechia
- Department
- Oddělení gastroenterologie, hepatologie a pankreatologie,
Research Overview
- N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
- Phase 2 Randomized, Placebo-Controlled Study of the Efficacy and Safety of Vamifeport in Adults with HFE-Related Hereditary Hemochromatosis
- Evaluation of Long-Term Safety and Tolerability of Seladelpar in Patients with Primary Biliary Cholangitis
Data & Insights
Has run more than one trial at 76 of 221 partner sites.
Specializations
Hepatic Disorders
The investigator specializes in the treatment of Primary Biliary Cholangitis (PBC), demonstrating particular interest in innovative therapeutic approaches for this chronic liver condition.
- Chronic liver diseases
- Autoimmune liver disorders
- Cholestatic conditions
Active involvement in evaluating novel treatments for patients with biliary disorders and associated complications.
Cholestatic Conditions
Focused expertise in managing cholestatic disorders and their symptoms, particularly cholestatic pruritus in patients with liver diseases.
- Pruritus management
- Bile acid disorders
- Symptom control
Dedicated to exploring therapeutic solutions for cholestasis-related complications and improving patient quality of life.
Long-term Treatment Assessment
Specialized in evaluating the long-term safety and tolerability of novel therapeutic agents for chronic liver conditions.
- Treatment safety monitoring
- Therapeutic effectiveness
- Patient outcomes
Experience in conducting extended duration studies to assess treatment sustainability and patient response.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.